ginsenoside rh2 has been researched along with mitoxantrone in 2 studies
Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
---|---|---|---|---|---|
295 | 1 | 200 | 4,555 | 1,042 | 1,004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bu, X; Bush, JA; Chen, X; Jia, WW; Li, G; Liu, G; Philips, D; Yan, H | 1 |
Eberding, A; Fazli, L; Gleave, M; Goldenberg, L; Guns, ES; Jia, W; Madera, C; Xie, X | 1 |
2 other study(ies) available for ginsenoside rh2 and mitoxantrone
Article | Year |
---|---|
Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ginsenosides; Humans; Mice; Mice, Inbred C57BL; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Panax; Plant Extracts; Receptors, Glucocorticoid; Tumor Suppressor Protein p53 | 2004 |
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.
Topics: Animals; Antineoplastic Agents; Drug Synergism; Drugs, Chinese Herbal; Ginsenosides; Humans; Male; Mice; Mice, Nude; Mitoxantrone; Paclitaxel; Prostatic Neoplasms; Tumor Cells, Cultured | 2006 |